Table of Contents
Who owns McKesson stock?
Top 10 Owners of Mckesson Corp
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 9.79% | 15,141,993 |
| BlackRock Fund Advisors | 5.08% | 7,860,240 |
| SSgA Funds Management, Inc. | 4.44% | 6,867,245 |
| JPMorgan Investment Management, I… | 4.17% | 6,455,250 |
What does McKesson Corporation do?
McKesson Corp. is one of the largest providers of medicines, pharmaceutical supplies and health information technology (IT) products and services in the United States. The company was founded in 1833 by John McKesson and Charles Olcott in New York with a focus on importing and wholesaling pharmaceutical products.
What is the largest pharmacy chain in Canada?
Shoppers
Shoppers, owned by Loblaw Companies, is the largest pharmacy chain in Canada, with more than 1,200 locations.
Does McKesson own Ida?
McKesson already owns IDA and Guardian pharmacies across Canada.
When is McKesson going to announce its dividend?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol “MCK.”. McKesson announced a quarterly dividend on Wednesday, July 31st. McKesson Co. (NYSE:MCK) issued its earnings results on Wednesday, July, 31st. McKesson is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019.
What is the payout ratio of McKesson Corporation?
The dividend payout ratio of McKesson is 10.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 8.91% next year. This indicates that McKesson will be able to sustain or increase its dividend.
What kind of business does McKesson Corporation do?
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical; International; Medical-Surgical Solutions; and Prescription Technology Solutions (“RxTS”).
What are the analysts price targets for MCK?
Their forecasts range from $166.00 to $261.00. On average, they anticipate McKesson’s stock price to reach $224.13 in the next year. This suggests a possible upside of 7.9% from the stock’s current price. View analysts’ price targets for McKesson or view top-rated stocks among Wall Street analysts.